申请人:Takeda Pharmaceutical Company Limited
公开号:EP2431367A2
公开(公告)日:2012-03-21
The present invention provides a compound represented by the formula (I):
wherein each symbol is as defined in the description, or a salt thereof, and pharmaceutical compositions comprising said compound, useful as insulin secretagogues or agents for the treatment of the diabetes (GPR40 receptor modulators).
本发明提供了一种由式 (I) 表示的化合物:
其中各符号如描述中所定义,或其盐,以及包含所述化合物的药物组合物,可用作胰岛素促泌剂或治疗糖尿病的药物(GPR40 受体调节剂)。